AT322251T
Botulinum toxin implat
Abstract
A biological adaptability implant, and article carried on the pair of an of the nonindividual body is released in a press to a 5 years treating period of. And the product is composed of a a coagulation of transfusion of polymer and specific, for example of the polymer to ethanoic and ethyl group ethene ester and. The specific of can be a botulinus device.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
44 members in 15 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 58725000 | United States of America | A | |
| 58725000 | United States of America | A | |
| 587250 | – | – | – |
| US20000587250 | – | – | – |
Members44
| Document | Office | Kind | |
|---|---|---|---|
| US6306423B1 | United States of America | B1 | |
| US6312708B1 | United States of America | B1 | |
| CA2411277A1 | Canada | A1 | |
| WO0193827A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0193890A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6504301A | Australia | A | |
| AU7292701A | Australia | A | |
| US2002028216A1 | United States of America | A1 | |
| US2002028244A1 | United States of America | A1 | |
| WO0193827A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0193890A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6383509B1 | United States of America | B1 | |
| WO0193827B1 | World Intellectual Property Organization (WIPO) | B1 | |
| WO0193890B1 | World Intellectual Property Organization (WIPO) | B1 | |
| US2002098237A1 | United States of America | A1 | |
| US6506399B2 | United States of America | B2 | |
| EP1289504A2 | European Patent Office (EPO) | A2 | |
| AR028669A1 | Argentina | A1 | |
| AR028670A1 | Argentina | A1 | |
| BR0111300A | Brazil | A | |
| US6585993B2 | United States of America | B2 | |
| KR20030066330A | Republic of Korea | A | |
| CN1446081A | China | A | |
| JP2003535117A | Japan | A | |
| US2004033241A1 | United States of America | A1 | |
| NZ522611A | New Zealand | A | |
| US2004170665A1 | United States of America | A1 | |
| US2005214327A1 | United States of America | A1 | |
| AU2001272927B2 | Australia | B2 | |
| TWI250020B | Taiwan Province of China | B | |
| AU2001272927B8 | Australia | B8 | |
| EP1289504B1 | European Patent Office (EPO) | B1 | |
| AT322251TThis record | Austria | T | |
| ATE322251T1 | Austria | T1 | |
| EP1655023A1 | European Patent Office (EPO) | A1 | |
| DE60118550D1 | Germany | D1 | |
| TWI255717B | Taiwan Province of China | B | |
| ES2259665T3 | Spain | T3 | |
| US2007020295A1 | United States of America | A1 | |
| DE60118550T2 | Germany | T2 | |
| KR100732810B1 | Republic of Korea | B1 | |
| CA2411277C | Canada | C | |
| CN100536915C | China | C | |
| JP2012067144A | Japan | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 322251
- Publication, EPODOC
- AT322251T
- Application
- 1952135
- Application, DOCDB
- 01952135
- Application, EPODOC
- AT20010952135T
Titles2
- German
- NEUROTOXIN IMPLANTAT
- English
- NEUROTOXIN IMPLANT
Classification
- CPC, 8
- A61K9/0024
- A61K9/00
- A61K38/4893
- Y10S514/964
- A61P21/00
- A61P21/02
- A61P25/00
- A61P25/14
- IPC, 11
- A61K9 16
- A61K9 00
- A61K9 22
- A61K31 28
- A61K38 00
- A61K38 48
- A61K47 32
- A61K47 34
- A61K47 42
- A61P21 02
- A61P25 00